Mayo Clinic Health Manager
Get free personalized health guidance for you and your family.
Get Started
About our e-newsletters
- Free e-newsletters
- Mayo Clinic expertise
- We do not share your e-mail address
Housecall, our weekly general-interest e-newsletter, keeps you up to date on a wide variety of health topics with timely, reliable, practical information, recipes, blogs, questions and answers with Mayo Clinic experts and more. Our biweekly topic-specific e-newsletters also include blogs, questions and answers with Mayo Clinic experts, and other useful information that will help you manage your health.
Housecall Archives
Mayo Clinic Housecall
Stay up to date on the latest health information.
What you get
- Free weekly e-newsletter
- Mayo Clinic expertise
- Recipes, tools and other helpful information
- We do not share your e-mail address
Definition
By Mayo Clinic staff
Graves' disease is the most common form of hyperthyroidism, occurring when your immune system mistakenly attacks your thyroid gland and causes it to overproduce the hormone thyroxine. This higher thyroxine level can greatly increase your body's metabolic rate, which may affect you in numerous ways, from your moods to your physical appearance.
Graves' disease is rarely life-threatening. Although it may develop at any age and in either men or women, Graves' disease is more common in women and usually begins after age 20.
There's no way to stop your immune system from attacking your thyroid gland, but treatments for Graves' disease can ease symptoms and decrease the production of thyroxine.
- Graves' disease. U.S. Department of Health and Human Services. http://www.endocrine.niddk.nih.gov/pubs/graves/Graves.pdf. Accessed April 23, 2009.
- Hyperthyroidism. American Association of Clinical Endocrinologists. http://www.aace.com/pub/thyroidbrochures/pdfs/Hyperthyroidism.pdf. Accessed April 23, 2009.
- Nyirenda MJ, et al. Thyroid-stimulating hormone-receptor antibody and thyroid hormone concentrations in smokers vs. nonsmokers with Graves' disease treated with carbimazole. Journal of the American Medical Association. 2009;301:162.
- Cawood TJ, et al. Smoking and thyroid-associated ophthalmopathy: A novel explanation of the biological link. The Journal of Clinical Endocrinology and Metabolism. 2007;92:59.
- Davies TF. Pathogenesis of Graves' disease. http://www.uptodate.com/home/index.html. Accessed April 27, 2009.
- Brent GA. Graves' disease. New England Journal of Medicine. 2008;358:2594.
- Rubin DI. Neurologic manifestations of hyperthyroidism and Graves' disease. http://www.uptodate.com/home/index.html. Accessed April 27, 2009.
- Davies TF. Treatment of Graves' ophthalmopathy (orbitopathy). http://www.uptodate.com/home/index.html. Accessed April 27, 2009.
- Nippoldt TB (expert opinion). Mayo Clinic, Rochester, Minn. May 13, 2009.
- Propylthiouracil-induced liver failure. U.S. Food and Drug Administration. Accessed June 17, 2009.
